← Leaderboards
Kevin James Erhart
Decimal, Inc.
$2,261,141
Attributed
$2,261,141
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.1M · FY2016–20$2M$1.5M$1M$500K$0
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$2,261,141 · 2
By mechanism
R44$2,000,000 · 1
R41$261,141 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Heterogeneity”
- Chanza Baytop · Westat, Inc.$271,217,917
- Richard A Gibbs · Baylor College Of Medicine$189,765,274
- Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$171,224,107
- James Dennis Neaton · Northwestern University$166,150,536
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Mary L. Disis · University Of Washington$91,659,868
Research focus
HeterogeneityMonte Carlo MethodElectron BeamElectronsMalignant NeoplasmsModalityDesignDoseCancer ControlElectron Beam TherapyIslandCancer TherapyBolus InfusionMeasurementCaliberCollimatorAlgorithmsDistalComputer SoftwareConformal RadiotherapyAcuteDensityDevicesNormal Tissue Morphology
Grant awards (3)
Product Development of Intensity Modulation for Bolus Electron Conformal Therapy$1,059,095
R44 · FY2020 · CA · contact PI
Product Development of Intensity Modulation for Bolus Electron Conformal Therapy$940,905
R44 · FY2019 · CA · contact PI
Product Development of Intensity Modulation for Bolus Electron Conformal Therapy$261,141
R41 · FY2016 · CA · contact PI